These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35681212)

  • 1. Detection of ovarian cancer using plasma cell-free DNA methylomes.
    Lu H; Liu Y; Wang J; Fu S; Wang L; Huang C; Li J; Xie L; Wang D; Li D; Zhou H; Rao Q
    Clin Epigenetics; 2022 Jun; 14(1):74. PubMed ID: 35681212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer.
    Liang L; Zhang Y; Li C; Liao Y; Wang G; Xu J; Li Y; Yuan G; Sun Y; Zhang R; Li X; Nian W; Zhao J; Zhang Y; Zhu X; Wen X; Cai S; Li N; Wu L
    EBioMedicine; 2022 Sep; 83():104222. PubMed ID: 35973389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cell-free DNA methylome-based liquid biopsy for accurate gastric cancer detection.
    Qi J; Hong B; Wang S; Wang J; Fang J; Sun R; Nie J; Wang H
    Cancer Sci; 2024 Oct; 115(10):3426-3438. PubMed ID: 39038922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
    Nuzzo PV; Berchuck JE; Korthauer K; Spisak S; Nassar AH; Abou Alaiwi S; Chakravarthy A; Shen SY; Bakouny Z; Boccardo F; Steinharter J; Bouchard G; Curran CR; Pan W; Baca SC; Seo JH; Lee GM; Michaelson MD; Chang SL; Waikar SS; Sonpavde G; Irizarry RA; Pomerantz M; De Carvalho DD; Choueiri TK; Freedman ML
    Nat Med; 2020 Jul; 26(7):1041-1043. PubMed ID: 32572266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility.
    Marinelli LM; Kisiel JB; Slettedahl SW; Mahoney DW; Lemens MA; Shridhar V; Taylor WR; Staub JK; Cao X; Foote PH; Burger KN; Berger CK; O'Connell MC; Doering KA; Giakoumopoulos M; Berg H; Volkmann C; Solsrud A; Allawi HT; Kaiser M; Vaccaro AM; Albright Crawford C; Moehlenkamp C; Shea G; Deist MS; Schoolmeester JK; Kerr SE; Sherman ME; Bakkum-Gamez JN
    Gynecol Oncol; 2022 Jun; 165(3):568-576. PubMed ID: 35370009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer.
    Widschwendter M; Zikan M; Wahl B; Lempiäinen H; Paprotka T; Evans I; Jones A; Ghazali S; Reisel D; Eichner J; Rujan T; Yang Z; Teschendorff AE; Ryan A; Cibula D; Menon U; Wittenberger T
    Genome Med; 2017 Dec; 9(1):116. PubMed ID: 29268796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA.
    Shen SY; Burgener JM; Bratman SV; De Carvalho DD
    Nat Protoc; 2019 Oct; 14(10):2749-2780. PubMed ID: 31471598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.
    Terp SK; Stoico MP; Dybkær K; Pedersen IS
    Clin Epigenetics; 2023 Feb; 15(1):24. PubMed ID: 36788585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer detection by DNA methylation in cervical scrapings.
    Wu TI; Huang RL; Su PH; Mao SP; Wu CH; Lai HC
    Clin Epigenetics; 2019 Nov; 11(1):166. PubMed ID: 31775891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma.
    Lasseter K; Nassar AH; Hamieh L; Berchuck JE; Nuzzo PV; Korthauer K; Shinagare AB; Ogorek B; McKay R; Thorner AR; Lee GM; Braun DA; Bhatt RS; Freedman M; Choueiri TK; Kwiatkowski DJ
    Genet Med; 2020 Aug; 22(8):1366-1373. PubMed ID: 32341571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can circulating cell free DNA be a promising marker in ovarian cancer? - a genome-scale profiling study in a single institution.
    Zhou H; Zhang X; Liu Q; Yang J; Bai J; Yin M; Cao D; Zhang Q; Zheng L
    J Ovarian Res; 2023 Jan; 16(1):11. PubMed ID: 36641505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OvaPrint-A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer.
    Buckley DN; Lewinger JP; Gooden G; Spillman M; Neuman M; Guo XM; Tew BY; Miller H; Khetan VU; Shulman LP; Roman L; Salhia B
    Clin Cancer Res; 2023 Dec; 29(24):5196-5206. PubMed ID: 37812492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alter circulating cell-free DNA variables in plasma of ovarian cancer patients.
    Yu Z; Qin S; Wang H
    J Obstet Gynaecol Res; 2019 Nov; 45(11):2237-2242. PubMed ID: 31502389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
    Singh A; Gupta S; Badarukhiya JA; Sachan M
    Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of cell-Free DNA methylation profiling with MeDIP-seq identified potential biomarkers for colorectal cancer.
    Zhang X; Li T; Niu Q; Qin CJ; Zhang M; Wu GM; Li HZ; Li Y; Wang C; Du WF; Wang CY; Zhao Q; Zhao XD; Wang XL; Zhu JB
    World J Surg Oncol; 2022 Jan; 20(1):21. PubMed ID: 35065650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer.
    Bahado-Singh RO; Ibrahim A; Al-Wahab Z; Aydas B; Radhakrishna U; Yilmaz A; Vishweswaraiah S
    Sci Rep; 2022 Nov; 12(1):18625. PubMed ID: 36329159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
    Li B; Pu K; Ge L; Wu X
    Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.
    Huang RL; Gu F; Kirma NB; Ruan J; Chen CL; Wang HC; Liao YP; Chang CC; Yu MH; Pilrose JM; Thompson IM; Huang HC; Huang TH; Lai HC; Nephew KP
    Epigenetics; 2013 Jun; 8(6):624-34. PubMed ID: 23774800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
    Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H
    Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study.
    Qiao G; Zhuang W; Dong B; Li C; Xu J; Wang G; Xie L; Zhou Z; Tian D; Chen G; Tang J; Zhou H; Zhang D; Shi R; Chen R; Nian W; Zhang Y; Zhao J; Wen X; Xu Y; Li B; Zhang Z; Cai S; Ben X; Qi Y
    BMC Med; 2021 Oct; 19(1):243. PubMed ID: 34641873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.